Holding(s) in Company

RNS Number : 5510S
Spire Healthcare Group PLC
14 July 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BNLPYF73

Issuer Name

SPIRE HEALTHCARE GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Bank of America Corporation

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

12-Jul-2022

6. Date on which Issuer notified

14-Jul-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

2.693596

3.135512

5.829108

23533679

Position of previous notification (if applicable)

0.000000

0.227526

0.227526


8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BNLPYF73


10874770


2.693596

Sub Total 8.A

10874770

2.693596%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Right to Recall

N/A

N/A

99187

0.024568

Sub Total 8.B1


99187

0.024568%

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Swaps

22/7/2022

N/A

Cash

3930000

0.973430

Swaps

29/7/2022

N/A

Cash

27078

0.006707

Swaps

16/11/2022

N/A

Cash

149936

0.037138

Swaps

4/1/2023

N/A

Cash

2770859

0.686320

Swaps

31/1/2023

N/A

Cash

1813

0.000449

Swaps

7/2/2023

N/A

Cash

1092000

0.270480

Swaps

3/5/2023

N/A

Cash

1780000

0.440892

Swaps

17/5/2023

N/A

Cash

2806000

0.695024

Swaps

30/6/2023

N/A

Cash

1465

0.000363

Swaps

27/12/2023

N/A

Cash

571

0.000141

Sub Total 8.B2


12559722

3.110944%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Bank of America Corporation

Merrill Lynch International



5.113802%

Bank of America Corporation

Bank of America, National Association




Bank of America Corporation

BofA Securities Europe SA




10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

14-Jul-2022

13. Place Of Completion

United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUSSSRUBUBAAR
UK 100

Latest directors dealings